Lymphoma Trial, Recruiting NCT02537769 Sponsor: University of Washington Condition: Lymphoma
Back to Lymphoma

Lymphoma Trial, Recruiting

NCT02537769
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • A participant or their legal representative has agreed to take part by signing a consent form
  • The person is over 18 years of age
  • The person has advanced heart failure with severe symptoms (classified as Stage III or IV), has a mild leaky tricuspid heart valve (a valve on the right side of the heart), and is already scheduled to receive a surgically implanted heart assist device called an LVAD

Who may not be able to join:

  • The person has previously had repair surgery on their tricuspid heart valve
  • There is evidence of physical damage to the structure of the tricuspid valve, such as problems with the cords or flaps of the valve
  • There are technical surgical obstacles that the investigator considers to carry an unusually high risk (confirm with trial site)
  • The person is already using a mechanical heart support device, other than a specific type called an intra-aortic balloon pump
  • The person has a Body Mass Index (a measure of body weight relative to height) above 45
  • The person is pregnant
  • The person has a mechanical aortic heart valve that will not be replaced with a tissue-based valve at the time of LVAD surgery
  • The person has previously had a heart transplant or a procedure called cardiomyoplasty (a surgery involving muscle wrapped around the heart)
  • The person has a psychiatric illness, significant memory or thinking difficulties, or social circumstances that are likely to make it hard to follow the study requirements and manage the LVAD device
  • The person has an active infection that is not under control
  • The person has evidence of liver disease, based on liver enzyme blood test results
  • The person has had a stroke in the 90 days before enrolling, or has a history of significant narrowing (more than 80%) of blood vessels leading to the brain
  • The person requires ongoing kidney dialysis
  • The person is already taking part in another clinical trial that could interfere with this study's results
  • The person has a condition other than heart failure that is likely to limit survival to less than one year
  • The person does not wish to take part in the study
  • The person is currently living in an institutional facility as an inmate

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Kei Togashi, MD, MPH, University of Washington

Phone: 206-616-1893

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 August 2015
Est. completion
1 December 2025

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change in TR severity assessment from baseline

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov